NCT00459277 2012-01-25Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular OpioidsArchimedes Development LtdPhase 3 Completed73 enrolled